FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

34033411000001101: Nortriptyline 25mg tablets (Focus Pharmaceuticals Ltd) 30 tablet 3 x 10 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Mar 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
103183601000001112 Nortriptyline 25mg tablets (Focus Pharmaceuticals Ltd) 30 tablet 3 x 10 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
111531801000001119 Nortriptyline 25mg tablets (Advanz Pharma) 30 tablet 3 x 10 tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Nortriptyline 25mg tablets (Focus Pharmaceuticals Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Nortriptyline 25mg tablets (Focus Pharmaceuticals Ltd) 30 tablet 3 x 10 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Nortriptyline 25mg tablets (Focus Pharmaceuticals Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Nortriptyline 25mg tablets (Focus Pharmaceuticals Ltd) 30 tablet 3 x 10 tablets Is a Nortriptyline 25mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Nortriptyline 25mg tablets (Focus Pharmaceuticals Ltd) 30 tablet 3 x 10 tablets Has AMP Nortriptyline 25mg tablets (Focus Pharmaceuticals Ltd) true Inferred relationship Existential restriction modifier
Nortriptyline 25mg tablets (Focus Pharmaceuticals Ltd) 30 tablet 3 x 10 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Nortriptyline 25mg tablets (Focus Pharmaceuticals Ltd) 30 tablet 3 x 10 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Nortriptyline 25mg tablets (Focus Pharmaceuticals Ltd) 30 tablet 3 x 10 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Nortriptyline 25mg tablets (Focus Pharmaceuticals Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient Nortriptyline hydrochloride true Inferred relationship Existential restriction modifier
Nortriptyline 25mg tablets (Focus Pharmaceuticals Ltd) 30 tablet 3 x 10 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Nortriptyline 25mg tablets (Focus Pharmaceuticals Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Nortriptyline true Inferred relationship Existential restriction modifier
Nortriptyline 25mg tablets (Focus Pharmaceuticals Ltd) 30 tablet 3 x 10 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Nortriptyline 25mg tablets (Focus Pharmaceuticals Ltd) 30 tablet 3 x 10 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Nortriptyline 25mg tablets (Focus Pharmaceuticals Ltd) 30 tablet 3 x 10 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Nortriptyline 25mg tablets (Focus Pharmaceuticals Ltd) 30 tablet 3 x 10 tablets Has basis of strength substance Nortriptyline true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start